RecruitingPhase IIEN originalLeukemia

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

maintenance of AML or MDS patients with known IDH1 mutation after allogeneic stem cell transplantation within past 100 days

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Białaczka ostra lub zespół mielodysplastyczny z mutacją IDH1

✗ Disqualifies

  • Aktywna choroba przeszczepowo-przeciwko-gospodarzowi stopnia III-IV wymagająca kortykosteroidów w dawce powyżej 1 mg/kg na dobę

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
75 Years
Last updated (source)
August 26, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (17)

Universitätsklinikum Aachen

Aachen, Germany

Klinikum Chemnitz gGmbH

Chemnitz, Germany

Technische Universitaet Dresden, Medizinische Klinik und Poliklinik I

Dresden, Germany

Universitaetsklinikum Erlangen AöR

Erlangen, Germany

Universitätsklinikum Essen

Essen, Germany

Goethe Universität Frankfurt / Universitätsklinikum Frankfurt

Frankfurt am Main, Germany

Universitätsmedizin Greifswald KöR

Greifswald, Germany

Martin-Luther-Universitaet Halle-Wittenberg

Halle, Germany

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

Universitätsklinikum Jena

Jena, Germany

Universitätsklinikum Schleswig-Holstein

Kiel, Germany

Universität Leipzig

Leipzig, Germany

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Mainz, Germany

Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)

München, Germany

Universität Münster

Münster, Germany

Rostock University Medical Center

Rostock, Germany

Universitaetsklinikum Ulm

Ulm, Germany

Trial contact

Jan Moritz Middeke, Dr. med.

Friedrich Stölzel, Prof. Dr. med.

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/27/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.